Advertisement
Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silbert, L. C.
Right arrow Articles by Kaye, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silbert, L. C.
Right arrow Articles by Kaye, J. A.
NEUROLOGY 2009;73:120-125
© 2009 American Academy of Neurology

Cognitive impairment risk

White matter hyperintensity progression matters
Lisa C. Silbert, MD, MCR, Diane B. Howieson, PhD, Hiroko Dodge, PhD and Jeffrey A. Kaye, MD

From the Department of Neurology (L.C.S., D.B.H., H.D., J.A.K.), Oregon Health & Science University, Portland; and Department of Neurology (L.C.S., J.A.K.), Veterans Affairs Medical Center, Portland, OR.

Address correspondence and reprint requests to Dr. Lisa Silbert, Layton Aging and Alzheimer’s Disease Center, Department of Neurology, CR-131, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd., Portland, OR 97239 silbertl{at}ohsu.edu

Objective: To determine whether white matter hyperintensity (WMH) progression rate is a better predictor of cognitive impairment risk than baseline WMH volume in healthy elderly individuals.

Method: Ninety-eight cognitively intact elderly subjects were followed in the Oregon Brain Aging Study. Forty-nine had at least 3 brain MRIs and annual cognitive and neurologic assessments until diagnosed with persistent cognitive impairment (PCI). Brain, ventricular CSF (vCSF), intracranial volume (ICV), hippocampus, total WMH, periventricular (PV) WMH, and subcortical WMH volumes were measured. Cox proportional hazards survival analyses were used to assess cognitive impairment risk.

Results: After adjusting for age, apolipoprotein E4 status, incident hypertension, ICV, entry Mini-Mental State Examination, baseline hippocampus, and both baseline vCSF volume and rate of vCSF volume change, increased progression of total WMH volume (hazard ratio [HR] 1.84, 95% confidence interval [CI] 1.3–2.7, p = 0.0007) and PV WMH volume (HR 1.94, 95% CI 1.3–3.1, p = 0.001) conferred higher risk of PCI, whereas baseline WMH volumes did not. Every 1 mL/y increase in PV WMH volume was associated with a 94% increased risk of PCI.

Conclusion: Progression of total and periventricular (PV) white matter hyperintensity (WMH) volumes are better predictors of persistent cognitive impairment (PCI) than baseline WMH burden. Greater PV WMH burden progression is associated with the development of PCI, a potential precursor to Alzheimer or vascular dementia. Identification of factors that decrease WMH accumulation over time is needed to maintain cognitive health in our growing elderly population.

Abbreviations: AD = Alzheimer disease; CDR = Dementia Rating Scale; CI = confidence interval; HR = hazard ratio; HS = hippocampal sclerosis; HTN = hypertension; ICV = intracranial volume; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; NA = not applicable; NS = not significant; PCI = persistent cognitive impairment; PV = periventricular; SES = socioeconomic status; TE = echo time; TR = repetition time; vCSF = ventricular CSF; vol = volume; WMH = white matter hyperintensity.

Supported in part by grants from the Department of Veterans Affairs and NIH (P30 AG 08017, M01 RR000334, and K23 AG 24826-01, K01AG023014), Paul B. Beeson Career Development Award in Aging, the Max Millis Fund for Neurological Research, and the Storms Family Fund at the Oregon Community Foundation.

Disclosure: Author disclosures are provided at the end of the article.

Received January 28, 2009. Accepted in final form April 2, 2009.




This article has been cited by other articles:


Home page
 BMJHome page
S. Debette and H. S. Markus
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis
BMJ, July 26, 2010; 341(jul26_1): c3666 - c3666.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Verdelho, S. Madureira, C. Moleiro, J. M. Ferro, C. O. Santos, T. Erkinjuntti, L. Pantoni, F. Fazekas, M. Visser, G. Waldemar, et al.
White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study
Neurology, July 13, 2010; 75(2): 160 - 167.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. B. Gorelick and J. V. Bowler
Advances in Vascular Cognitive Impairment
Stroke, February 1, 2010; 41(2): e93 - e98.
[Full Text] [PDF]

Home page
 StrokeHome page
R. F. Gottesman, J. Coresh, D. J. Catellier, A. R. Sharrett, K. M. Rose, L. H. Coker, D. K. Shibata, D. S. Knopman, C. R. Jack, and T. H. Mosley Jr
Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort: Atherosclerosis Risk in Communities (ARIC) Study
Stroke, January 1, 2010; 41(1): 3 - 8.
[Abstract] [Full Text] [PDF]


Advertisement